The first Medical Device Regulatory Summit in India is being held at Holiday Inn Mumbai International Airport on 29 November 2016. Morulaa HealthTech is pleased to partner at this event.

Medical Device Regulatory Summit 2016, is an event intended to raise awareness of the need for clarity on regulations, Intellectual properties and export & import guidelines for the Indian Market. The salient features/points of the Summit are,

  • Reviewing regulatory and compliance landscape in the medical device industry
  • Looking at specifications in the evolving regulations to create a strong and compliant framework within the organization.

Mrs. Harshita Gupta, Director of our Company has been invited to give a talk at the Summit. She will be speaking on ‘Regulatory Requirements to Import Medical Devices: Current Scenario and Future Possibilities’. Morulaa HealthTech is one of the leading companies from India that provides market access and regulatory solutions for medical devices and healthcare companies.

As a value add, enclosed is the link to the proposed Medical Device Legislation 2016. To read click here

Knowledge sharing session at the summit:

Topic: Regulatory Requirements to Import Medical Devices: Current Scenario and Future Possibilities

Speaker: Harshita Gupta, Director – Morulaa HeathTech

Key Points Covered:

  • Overview of the steps to fulfill the current regulatory requirements for importation
  • Key document requirements including labeling
  • Benefits of the SUGAM online portal to apply for the import licenses and registration certificates
  • Key roles and responsibilities of the Authorized Indian Agent
  • Current Timelines for obtaining the licenses
  • What to expect from the Updated Medical Device Draft 2016 if you are an Importer

To know more about Morulaa HealthTech’s services in the medical device and healthcare sector, click here

To download a program brochure, click here

Contact us at info@morulaa.com to learn more and attend our talk as a delegate at the Medical Device Regulatory Summit in Mumbai.

Other News

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More

TGA Supports MHRA’s New Regulations

The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]

Read More

Medical Devices with Extended CE Certification Are Now Accepted On The UK Market

The MHRA revised its guidelines to make clear its stance and reflect its intention to extend the acceptance of CE-marked medical devices on the British market beyond June 30th, 2023. A statutory document that will […]

Read More

The NMPA Enhanced Regulation of Cosmetic Medicine

According to a representative of the State Administration for Market Regulation, after the industry’s quick development, prominent issues like unethical medical practices, fake goods, false advertising, and price fraud emerged, endangering the health and interests […]

Read More

Radiation Sterilization Master File Pilot Program Announced by CDRH

CDRH is establishing a Radiation Sterilization Master File Pilot Program to assist businesses in developing less troublesome regulatory methods for sterilizing licensed medical equipment, such as switching radiation sources. The pilot program, which is optional, […]

Read More